|
1
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wooster R, Bignell G, Lancaster J, Swift
S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C and Micklem G:
Identification of the breast cancer susceptibility gene BRCA2.
Nature. 378:789–792. 1995. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Guan Y, Hata N, Kuga D, Yoshimoto K,
Mizoguchi M, Shono T, Suzuki SO, Tahira T, Kukita Y, Higasa K, et
al: Narrowing of the regions of allelic losses of chromosome 1p36
in meningioma tissues by an improved SSCP analysis. Int J Cancer.
122:1820–1826. 2008. View Article : Google Scholar
|
|
4
|
Zwahlen D, Tschan MP, Grob TJ, Peters UR,
Fink D, Haenggi W, Altermatt HJ, Cajot JF, Tobler A, Fey MF, et al:
Differential expression of p73 splice variants and protein in
benign and malignant ovarian tumours. Int J Cancer. 88:66–70. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Song SW, Fuller GN, Zheng H and Zhang W:
Inactivation of the invasion inhibitory gene IIp45 by alternative
splicing in gliomas. Cancer Res. 65:3562–3567. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Song SW, Fuller GN, Khan A, Kong S, Shen
W, Taylor E, Ramdas L, Lang FF and Zhang W: IIp45, an insulin-like
growth factor binding protein 2 (IGFBP-2) binding protein,
antagonizes IGFBP-2 stimulation of glioma cell invasion. Proc Natl
Acad Sci USA. 100:13970–13975. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang Y, Wen J and Zhang W: MIIP, a
cytoskeleton regulator that blocks cell migration and invasion,
delays mitosis, and suppresses tumorogenesis. Curr Protein Pept
Sci. 12:68–73. 2011. View Article : Google Scholar
|
|
8
|
Ji P, Smith SM, Wang Y, Jiang R, Song SW,
Li B, Sawaya R, Bruner JM, Kuang J, Yu H, et al: Inhibition of
gliomagenesis and attenuation of mitotic transition by MIIP.
Oncogene. 29:3501–3508. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Song F, Ji P, Zheng H, Song F, Wang Y, Hao
X, Wei Q, Zhang W and Chen K: Definition of a functional single
nucleotide polymorphism in the cell migration inhibitory gene MIIP
that affects the risk of breast cancer. Cancer Res. 70:1024–1032.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang Y, Yang D, Cogdell D, Hu L, Xue F,
Broaddus R and Zhang W: Genomic characterization of gene
copy-number aberrations in endometrial carcinoma cell lines derived
from endometrioid-type endometrial adeno carcinoma. Technol Cancer
Res Treat. 9:179–189. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cairns P, Evron E, Okami K, Halachmi N,
Esteller M, Herman JG, Bose S, Wang SI, Parsons R and Sidransky D:
Point mutation and homozygous deletion of PTEN/MMAC1 in primary
bladder cancers. Oncogene. 16:3215–3218. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fujita T, Igarashi J, Okawa ER, Gotoh T,
Manne J, Kolla V, Kim J, Zhao H, Pawel BR, London WB, et al: CHD5,
a tumor suppressor gene deleted from 1p36.31 in neuroblastomas. J
Natl Cancer Inst. 100:940–949. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
14
|
Chosdol K, Misra A, Puri S, Srivastava T,
Chattopadhyay P, Sarkar C, Mahapatra AK and Sinha S: Frequent loss
of heterozy-gosity and altered expression of the candidate tumor
suppressor gene ‘FAT’ in human astrocytic tumors. BMC Cancer.
9:52009. View Article : Google Scholar
|
|
15
|
Schwarzenbach H, Muller V, Beeger C,
Gottberg M, Stahmann N and Pantel K: A critical evaluation of loss
of heterozygosity detected in tumor tissues, blood serum and bone
marrow plasma from patients with breast cancer. Breast Cancer Res.
9:R662007. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xu XM, Qian JC, Cai Z, Tang T, Wang P,
Zhang KH, Deng ZL and Cai JP: DNA alterations of microsatellite
DNA, p53, APC and K-ras in Chinese colorectal cancer patients. Eur
J Clin Invest. 42:751–759. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hanahan D and Weinberg RA: The hallmarks
of cancer. Cell. 100:57–70. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wu Y, Song SW, Sun J, Bruner JM, Fuller GN
and Zhang W: IIp45 inhibits cell migration through inhibition of
HDAC6. J Biol Chem. 285:3554–3560. 2010. View Article : Google Scholar :
|
|
19
|
Hata N, Yoshimoto K, Yokoyama N, Mizoguchi
M, Shono T, Guan Y, Tahira T, Kukita Y, Higasa K, Nagata S, et al:
Allelic losses of chromosome 10 in glioma tissues detected by
quantitative single-strand conformation polymorphism analysis. Clin
Chem. 52:370–378. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cvetkovic D, Pisarcik D, Lee C, Hamilton
TC and Abdollahi A: Altered expression and loss of heterozygosity
of the LOT1 gene in ovarian cancer. Gynecol Oncol. 95:449–455.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wegman PP, Marcus NJ, Malakkaran BP and
Wingren S: Biological significance of allele specific loss of the
p53 gene in breast carcinomas. Breast Cancer Res Treat. 118:15–20.
2009. View Article : Google Scholar
|
